BMJ Innovations最新文献

筛选
英文 中文
Biomechanical analysis of delivering chest compressions in virtual reality simulation: preliminary insights into fidelity and validity of virtual reality as a means of delivering life support training 在虚拟现实模拟中进行胸外按压的生物力学分析:对虚拟现实作为生命支持培训手段的逼真性和有效性的初步认识
IF 2
BMJ Innovations Pub Date : 2024-09-07 DOI: 10.1136/bmjinnov-2024-001234
Aimee Rowe, Matthew A Ellison, Karamveer Narang, Alex Saunders, Steve Furnell, Jagtar Dhanda
{"title":"Biomechanical analysis of delivering chest compressions in virtual reality simulation: preliminary insights into fidelity and validity of virtual reality as a means of delivering life support training","authors":"Aimee Rowe, Matthew A Ellison, Karamveer Narang, Alex Saunders, Steve Furnell, Jagtar Dhanda","doi":"10.1136/bmjinnov-2024-001234","DOIUrl":"https://doi.org/10.1136/bmjinnov-2024-001234","url":null,"abstract":"#### WHAT ARE THE NEW FINDINGS #### HOW MIGHT THIS IMPACT HEALTHCARE IN THE FUTURE Virtual reality (VR) is a promising modality for healthcare education with ample qualitative evaluation.1–3 There is meagre quantitative study of using VR in healthcare training. This study aims to gain quantitative and qualitative insights into the fidelity and validity of cardiopulmonary resuscitation (CPR) training using VR. Good quality, timely chest compressions improve survival outcomes in cardiac arrest.4–6 Traditionally, chest compressions are taught to healthcare professionals (HCPs) as part of resuscitation training using manikin-based simulation.4 Resuscitation bodies, such as The European Resuscitation Council and Resuscitation Council UK, certify trainers to deliver CPR training using scenario-based simulation with manikins. Delivering this training has logistical barriers; accessing space, equipment, staff and time to conduct training. E-learning has been widely adopted in healthcare education, helping to reduce the logistical burden of providing mandatory training to the healthcare workforce.7 Emerging technology such as VR is appealing as it has the flexibility associated with e-learning while offering a more immersive experience,8 along with the potential to increase global accessibility and reduce the environmental impact of in-person training. Novel approaches must be assessed for efficacy before committing resources to their implementation. While there are data exploring VR use for CPR training,9–11 there …","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142190543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
iCount: a human-factors engineered solution to vaginal swab retention – an early-stage innovation report iCount:针对阴道拭子滞留问题的人因工程解决方案--早期创新报告
IF 2
BMJ Innovations Pub Date : 2024-08-30 DOI: 10.1136/bmjinnov-2024-001248
Ahmed Nader Elgharably, Kiran Desai, Alan Michael Nevill, Aaron Vance, Jon Lester, Emma Bonfiglio, Colin Rigby, Andrew Forrester, Peter Ogrodnik, Jeffrey Faint, Tom Clutton-Brock, Aditi Desai
{"title":"iCount: a human-factors engineered solution to vaginal swab retention – an early-stage innovation report","authors":"Ahmed Nader Elgharably, Kiran Desai, Alan Michael Nevill, Aaron Vance, Jon Lester, Emma Bonfiglio, Colin Rigby, Andrew Forrester, Peter Ogrodnik, Jeffrey Faint, Tom Clutton-Brock, Aditi Desai","doi":"10.1136/bmjinnov-2024-001248","DOIUrl":"https://doi.org/10.1136/bmjinnov-2024-001248","url":null,"abstract":"### WHAT ARE THE NEW FINDINGS #### HOW MIGHT IT IMPACT ON HEALTHCARE IN THE FUTURE Although uncommon, unintentionally retained surgical items remain a persistent and poorly understood medical error with the potential to cause significant harm. They are termed patient safety ‘never events’ and are considered unacceptable and largely preventable.1 The most commonly retained surgical item is the surgical swab, also known as ‘sponge’ in the USA, with the highest rates of swab retention found in the maternity setting. The UK never events database identifies vaginal swabs (used during perineal trauma repair) as the source of the largest number of swab retention events.2 3 NHS England data identifies 338 separate incidents of vaginal swab retention between 2012 and 2022 with evidence of global under-reporting due to the significant reputational impacts of these incidents as well as the difficulty in diagnosis and identification of error.1 3–6 This long-standing problem, also called ‘Gossypiboma’, was first reported in 1884 by the American Obstetrician and Gynaecologist Dr Wilson. …","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142190544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guidelines and regulations applicable to vitro diagnostic tests in the UK: a scoping review 英国适用于体外诊断检测的指南和法规:范围界定审查
IF 1.4
BMJ Innovations Pub Date : 2024-08-08 DOI: 10.1136/bmjinnov-2024-001238
Magdalena Staworko, Oscar Khawar, Frank Sullivan, Peter D Donnelly, Jon Deeks, Margaret McCartney
{"title":"Guidelines and regulations applicable to vitro diagnostic tests in the UK: a scoping review","authors":"Magdalena Staworko, Oscar Khawar, Frank Sullivan, Peter D Donnelly, Jon Deeks, Margaret McCartney","doi":"10.1136/bmjinnov-2024-001238","DOIUrl":"https://doi.org/10.1136/bmjinnov-2024-001238","url":null,"abstract":"To describe recommendations applicable to new diagnostic and screening tests brought to market in the UK as of 01 June 2023; and extract agreements, disagreements and gaps.Extant regulations, recommendations and guidelines for new diagnostic and screening tests applicable to new products placed in the UK market as of 01 June 2023. Non-English and references not applicable to new tests seeking market access in the UK on 01 June 2023 were excluded.PubMed, Web of Science Core Collection and Scopus; grey literature via EuropePMC and Google, government regulations and guidelines, and relevant professional societies. References of relevant included data were scanned for includable articles. Resultant data were thematically analysed and presented as a narrative scoping review.PubMed, Web of Science Core Collection and Scopus were searched from 1/1/2018 for regulations, guidelines or recommendations for in vitro diagnositic tests as applied to the UK on 1/6/23. Relevant papers also had references searched.943 items were initially identified with 892 excluded. Reference searching located a further 31 papers and 82 items were analysed. Seven themes were identified: regulation, companion diagnostics and lab developed tests, safety and evidence, test specific recommendations, data, innovation and recommendations for patients/the public. Wide agreement included the need to reduce bureaucracy and duplication; to mitigate to avoid unintended consequences of In Vitro Diagnostic Regulation. Disagreement over whether high-quality evidence should precede regulatory approval, or could be gathered as part of postmarketing surveillance emerged.Industry, regulators, academics, patients representing a variety of views, should collaborate to work through areas of disagreement.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141929164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spreading and scaling innovation and improvement: understanding why the differences matter 推广和扩大创新与改进:了解差异为何重要
IF 2
BMJ Innovations Pub Date : 2024-07-29 DOI: 10.1136/bmjinnov-2024-001251
Helen Bevan, Diane Ketley, Roseanna Cawthorne, Charitini Stavropoulou, Harry Scarbrough
{"title":"Spreading and scaling innovation and improvement: understanding why the differences matter","authors":"Helen Bevan, Diane Ketley, Roseanna Cawthorne, Charitini Stavropoulou, Harry Scarbrough","doi":"10.1136/bmjinnov-2024-001251","DOIUrl":"https://doi.org/10.1136/bmjinnov-2024-001251","url":null,"abstract":"In this paper, we make a distinction between spreading and scaling innovations and spreading and scaling good practices for improvement, as many healthcare change practitioners often feel there is a “muddle” between them. We argue there are multiple factors where the spread and scale factors are similar for innovation and improvement, such as enabling leadership, the capacity and capability for spread and scale, a process of behaviour change, use of data and evidence and system alignment. However, there are multiple characteristics that may be different, including the level of complexity, the nature of the intervention, the approach to fidelity and adaptability, the source of the innovation or improvement and the outcome metrics. These insights enable us to be better equipped to design and deliver successful spread and scale strategies tailored to the specific intervention and situation and realise the full benefits of our change initiatives.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141862813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stanford Emergency Medicine Partnership Program: a novel approach to streamlining the evaluation and implementation of emerging health technologies through academic–industry partnerships 斯坦福大学急诊医学合作计划:通过学术界与产业界合作,简化新兴医疗技术评估和实施的新方法
IF 2
BMJ Innovations Pub Date : 2024-06-12 DOI: 10.1136/bmjinnov-2023-001154
John Dayton, M. Y. Yiadom, Sam Shen, Matthew C Strehlow, Christian Rose, Gabrielle Bunney, R. Ribeira
{"title":"Stanford Emergency Medicine Partnership Program: a novel approach to streamlining the evaluation and implementation of emerging health technologies through academic–industry partnerships","authors":"John Dayton, M. Y. Yiadom, Sam Shen, Matthew C Strehlow, Christian Rose, Gabrielle Bunney, R. Ribeira","doi":"10.1136/bmjinnov-2023-001154","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001154","url":null,"abstract":"","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141353233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospitals as medical device manufacturers: keeping to the Medical Device Regulation (MDR) in the EU 作为医疗器械制造商的医院:遵守欧盟医疗器械法规 (MDR)
IF 2
BMJ Innovations Pub Date : 2024-06-05 DOI: 10.1136/bmjinnov-2023-001150
Gerard Boyle, Tom Melvin, Rudolf M Verdaasdonk, Robert A Van Boxtel, R. Reilly
{"title":"Hospitals as medical device manufacturers: keeping to the Medical Device Regulation (MDR) in the EU","authors":"Gerard Boyle, Tom Melvin, Rudolf M Verdaasdonk, Robert A Van Boxtel, R. Reilly","doi":"10.1136/bmjinnov-2023-001150","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001150","url":null,"abstract":"In the European Union, the introduction of the Medical Device Regulation (MDR) 2017/745 in 2021 increased the regulatory requirements for ‘in-hospital’ manufacture of medical devices. Depending on the exact scenario, a hospital manufacturing devices will need to consider applying one of three sets of regulatory requirements defined in the MDR: a reduced set of rules called the ‘health institution exemption’, which can be availed of under certain conditions; rules that apply for the manufacture of custom-made devices; or, exceptionally and most onerously, the same ‘full’ set of rules that apply to commercial medical device manufacturers. The purpose of this discussion is to provide an introductory guide to compliance with the MDR for in-hospital manufacture, highlighting the main regulatory requirements and the factors which determine which of the three ‘routes’ is the most appropriate.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141384251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovation adoption, use and implementation in emergency departments during the COVID-19 pandemic 在 COVID-19 大流行期间,急诊科采用、使用和实施创新技术
IF 2
BMJ Innovations Pub Date : 2024-04-25 DOI: 10.1136/bmjinnov-2023-001206
Shreya S Huilgol, Carl T Berdahl, Nabeel Qureshi, Catherine C Cohen, Peter Mendel, Shira H Fischer
{"title":"Innovation adoption, use and implementation in emergency departments during the COVID-19 pandemic","authors":"Shreya S Huilgol, Carl T Berdahl, Nabeel Qureshi, Catherine C Cohen, Peter Mendel, Shira H Fischer","doi":"10.1136/bmjinnov-2023-001206","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001206","url":null,"abstract":"During a public health emergency like the COVID-19 pandemic, emergency department (ED) clinicians may be able to save more lives if they rapidly identify and implement innovations that are safe and effective. However, there is little research examining clinician decision-making around innovation implementation during public health emergencies and when evidence-based information is limited.The goals of this study were to understand how ED clinicians decided to implement innovations and to describe the facilitators and challenges they faced during implementation.We conducted 3 pilot interviews and 13 focus group discussions with clinicians from eight hospital-based EDs across the USA. Seventeen physicians, seven advanced practice providers, 18 nurses and seven respiratory therapists participated. We used inductive and deductive techniques to perform content and thematic analysis of focus group transcripts.Participants cited social media, clinician autonomy, limited resources, organisational culture, supportive leadership and outside experiences as facilitators of trying innovations. Challenges in trying new innovations included limited evidence-based information, evolving guidelines, fear, moral distress and clinician pushback. Facilitators of using innovations in practice included leadership advocating for continued use, signs of patient improvement, ease of adoption and adequate resources. Challenges were the lack of familiarity, no established protocol and limited information dissemination about best practices.Our study highlights factors that influenced innovation adoption and implementation in EDs during the COVID-19 pandemic, including how fear and moral distress affected decision-making. Organisations can support the implementation of promising innovations by selecting strong leaders, ensuring clinician psychological safety, providing protocols and resources and highlighting successes.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140658372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Description and evaluation of a self-operated waist measurement device 自动腰围测量装置的描述和评估
IF 2
BMJ Innovations Pub Date : 2024-04-25 DOI: 10.1136/bmjinnov-2023-001162
Yilin Song, Kenneth A Philbrick, Alexander D Weston, Theodora Potretzke, Kelli A Lytle, Teresa Jensen, Michael D Jensen
{"title":"Description and evaluation of a self-operated waist measurement device","authors":"Yilin Song, Kenneth A Philbrick, Alexander D Weston, Theodora Potretzke, Kelli A Lytle, Teresa Jensen, Michael D Jensen","doi":"10.1136/bmjinnov-2023-001162","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001162","url":null,"abstract":"National guidelines recommend that waist circumference (WC) be measured in patients with a body mass index (BMI) 27–35 kg/m2. Unfortunately, perhaps due to logistical reasons, WC is seldom measured in clinical settings. Herein, we describe the performance of a self-operated waist measurement device (SOWMD) as a potential means to overcome barriers to measuring WC.Ten volunteers underwent WC measures by professionals and SOWMD on 5 separate days to assess the reproducibility and accuracy. We then compared SOWMD measures with CT-derived fat content by recruiting 81 patients scheduled for a diagnostic abdominal CT scan.There was no difference between professionally measured and SOWMD-measured WC; the intraindividual coefficient of variation over the 5 days was between 0.4% and 2.2%. The WC measured manually, by SOWMD and CT scan were highly correlated (r=0.90–0.92, all p<0.001). The minimal WC measured by SOWMD was a better predictor (r=0.81 for all patients, r=0.87 for men, both p<0.001) of CT-measured visceral adipose tissue volume than other approaches. The minimal WC measured by SOWMD was correlated with fasting plasma glucose (r=0.40, p<0.05), triglyceride (r=0.41, p<0.01) and high-density cholesterol (r=−0.49, p<0.001) concentrations.SOWMD is a reproducible, accurate and convenient way to measure WC that can provide added value for health care providers when combined with BMI information.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140658338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of twinnings in scaling up innovative solutions across Europe 姊妹大学在全欧洲推广创新解决方案方面的作用
IF 2
BMJ Innovations Pub Date : 2024-03-15 DOI: 10.1136/bmjinnov-2023-001141
Cláudia Campos, Robbin Kappelhof, Joana Carrilho, Luis Midão, Diogo Henriques, Elísio Costa
{"title":"Role of twinnings in scaling up innovative solutions across Europe","authors":"Cláudia Campos, Robbin Kappelhof, Joana Carrilho, Luis Midão, Diogo Henriques, Elísio Costa","doi":"10.1136/bmjinnov-2023-001141","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001141","url":null,"abstract":"Introduction Twinnings are cross-border knowledge exchange activities where two or more organisations learn from each other’s experiences and are often used as a scaling up mechanism. Objectives This paper discusses the importance of twinning activities in scaling up by promoting community building, knowledge sharing and innovation transfer among stakeholders in European countries. It explores the role of twinnings in the scaling up model of the European Innovation Partnership on Active and Healthy Ageing) and the Innovation Networks for Scaling Active and Healthy Ageing (IN-4-AHA) project. Methods The study employed a qualitative approach, drawing insights from various sources, including the Scale AHA study (2017), the IN-4-AHA’s scaling up model and twinning reports. Results The findings reveal that twinning activities provide stakeholders with a unique opportunity to learn from the know-how of other like-minded partners, improve the quality of their work and iterate on their innovations. They also highlight that twinnings are particularly relevant for some stages in the scaling up process, such as in the assessment of a network of potential partners and during the evaluation of the environment, the innovation could potentially be transferred to. Conclusion Twinnings are highly regarded as community-building and knowledge-sharing activities with clear advantages for companies and other stakeholder groups. Including twinning activities in the scaling up model has proven benefits for companies and projects that have a strong need for community building and innovation transfer. Data sharing not applicable as no data sets generated and/or analysed for this study.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140156795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wings of Healing: regulatory landscape, case studies and the Indian prologue of drones in healthcare 医治之翼:无人机在医疗保健领域的监管格局、案例研究和印度序幕
IF 2
BMJ Innovations Pub Date : 2024-03-05 DOI: 10.1136/bmjinnov-2023-001179
Ankita Sharma, Anju Vijayan, Pavan Ananth, Deepshikha Chhetri, Rahul Konapur, Nachiket Gudi
{"title":"Wings of Healing: regulatory landscape, case studies and the Indian prologue of drones in healthcare","authors":"Ankita Sharma, Anju Vijayan, Pavan Ananth, Deepshikha Chhetri, Rahul Konapur, Nachiket Gudi","doi":"10.1136/bmjinnov-2023-001179","DOIUrl":"https://doi.org/10.1136/bmjinnov-2023-001179","url":null,"abstract":"The healthcare sector is among the most rapidly expanding sectors. Drones are increasingly being used to reach the unreached in healthcare. Drones exhibit profound significance by overcoming accessibility challenges and offering versatile solutions. The future of healthcare is in the air, and new government initiatives uncover the country’s rapid market growth. Investments in drone technologies are rising, with research predicting significant drone expansion in the upcoming decade. Since this sector is still in its nascent stage, the time is ripe for stakeholders to collectively work for the effective implementation of drone technology in India. In this context, the paper seeks to bridge existing knowledge gaps by analysing the global regulatory landscape, the evolution of drones in India, used cases in healthcare, and the barriers that constrain their deployment in the healthcare domain. It explores the obstacles that hinder the widespread adoption of drones. Addressing these challenges becomes essential in unlocking the full potential of drone technology in revolutionising healthcare delivery, enhancing patient outcomes and overcoming logistical constraints. The report argues about the potential shift drones can bring to healthcare delivery while underlining the necessity of addressing regulatory concerns and fostering public trust.","PeriodicalId":53454,"journal":{"name":"BMJ Innovations","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2024-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140045281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信